Verve Therapeutics Launches with $58.5M in Series A Funding

Retrieved on: 2019-05-06 19:15:00

Tags for this article:

Click the tags to see associated articles and topics

Verve Therapeutics Launches with $58.5M in Series A Funding. View article details on hiswai:

Excerpt

<div>The round was led by GV (formerly <b>Google Ventures</b>), with participation from ARCH Venture Partners, F-Prime Capital, and Biomatics Capital.</div>

Article found on:

View Original Article